Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study
A descriptive open-label observational study of ibogaine in people with opioid use disorder found the drug can produce clear but reversible heart and nervous-system side effects. Reported effects included QTc prolongation (a change in the heart’s electrical timing), slow heart rate (bradycardia), and severe problems with balance and coordination (ataxia).…